Status:

UNKNOWN

Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery

Lead Sponsor:

Peking Union Medical College Hospital

Collaborating Sponsors:

Beijing Tongren Hospital

Xuanwu Hospital, Beijing

Conditions:

Arterial Occlusive Diseases

Vascular Diseases

Eligibility:

All Genders

45-80 years

Phase:

PHASE4

Brief Summary

Different strategies exist in the treatment of chronic long occlusion of the superficial femoral artery. Traditionally, these patients should be treated with bypass. If the great saphenous vein is una...

Detailed Description

This is a multi-center, prospective, randomized, controlled trial to compare the therapeutic effect of stent and artificial blood vessel bypass to chronic long occlusion of the superficial femoral art...

Eligibility Criteria

Inclusion

  • The patients volunteer to join the trial and sign the formal consent.
  • The patients are ≥45 year-old and ≤80 year-old.
  • The patients suffer from symptomatic leg ischemia with rutherford classification3, 4 , 5 or 6. The presentation is severe intermittent claudication, rest pain, ulcer or gangrene.
  • The total length of the femoral and popliteal artery lesion(including ≥75% stenosis and occlusion) are at least 15cm.
  • The femoral-popliteal artery has never received bypass or endovascular therapy before.
  • No obvious stenosis or occlusion in the aortoiliac artery; or the lesion could be treated simultaneously or has already been cured.
  • No obvious stenosis in below-knee popliteal artery; at least 1 vessel infra-popliteal runoff to the foot.
  • No surgical contraindications;no infection in operation region.
  • No available saphenous vein.

Exclusion

  • Refuse random treatment.
  • Previous operations on the superficial femoral artery.
  • Acute lower extremity arterial thrombosis.
  • Serious major organ failure.
  • Allergic to the contrast agent or has contrast nephropathy.
  • No clinical compliance or unfit to join the trial.

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2015

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01147419

Start Date

June 1 2010

End Date

June 1 2015

Last Update

July 7 2010

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100032

2

Xuanwu Hospital, Beijing

Beijing, Beijing Municipality, China, 100053

3

Beijing Tongren Hospital

Beijing, Beijing Municipality, China, 100730